Helius Medical Technologies Inc - Ordinary Shares - Class A

NASDAQ:HSDT  
1.46
-0.02 (-1.35%)
Earnings Announcements

Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results And Provides Update On U.S. Commercial Launch Of Pons

Published: 05/12/2022 11:05 GMT
Helius Medical Technologies Inc - Ordinary Shares - Class A (HSDT) - Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of Pons®.
Q1 Loss per Share $1.15.
Projected Cash Flow Positive Operations by Q4 2023.
Revenue is expected to be $0.36 Million
Adjusted EPS is expected to be -$1.12

Next Quarter Revenue Guidance is expected to be $0.93 Million
Next Quarter EPS Guidance is expected to be -$1.08

More details on our Analysts Page.